# Deflazacort Oral Suspension

NDC: 70710-2007
Generic name: Deflazacort
Labeler / Manufacturer: Zydus Pharmaceuticals (USA) Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20251023

FDA application: ANDA220042

## Active ingredients

- DEFLAZACORT: 22.75 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70710-2007"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70710-2007
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=14569f71-573e-49fd-b80e-b3b52531b1c8